BioSpace News Archive

Botanical Solution Inc has successfully closed $6.1 million in a Series A round led by Palo Alto based VC Firm, Otter Capital.

Select Medical Holdings Corporation (“Select Medical,” “we,” “us,” or “our”) (NYSE: SEM) today announced an estimate of certain results for its full year ended December 31, 2021 in advance of the announcement of actual results. Select Medical will release its actual financial results for its fourth quarter and full year ended December 31, 2021.

CANbridge Pharmaceuticals Inc. announced that the Chinese National Medical Products Administration has accepted the New Drug Application for CAN108 ) for the treatment of cholestatic pruritus in patients with Alagille syndrome 1 year of age and older.

Abbisko Therapeutics Co., Ltd., a subsidiary of Abbisko Cayman Limited, announced that it has entered into a worldwide collaboration and exclusive licensing agreement with Eli Lilly and Company for the further discovery, development and potential commercialization of novel molecules against an undisclosed target for cardiometabolic diseases with critical unmet medical needs.